Amedisys — Q4 2024 Earnings Presentation
14 slides from Amedisys's earnings presentation, Feb 26, 2025
Slide 1: Amedisys Fourth Quarter 2024 Earnings Release Supplemental Slides
1 Amedisys Fourth Quarter 2024 Earnings Release Supplemental Slides February 26th, 2025 Exhibit 99.2
Slide 2: Forward-Looking Statements
2 This presentation may include forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current expectations and assumptions about our business that are subject to a variety of risks and uncertainties that could c
Slide 3: Our Key Areas of Focus
3 OUR KEY AREAS OF FOCUS Strategic areas of focus and progress made during 4Q’24. • Home Health: Total same store admissions +8% • Hospice: Total same store ADC +0.5% • High Acuity Care: Admissions +29% 1 Organic Growth • Quality: Amedisys Jan’25 STARS score of 4.18 • 88% of care centers at 4+ Stars
Slide 4: Highlights and Summary Financial Results (Adjusted): 4Q'24
4 HIGHLIGHTS AND SUMMARY FINANCIAL RESULTS (ADJUSTED): 4Q’24(1) 1. The financial results for the three-month periods and years ended December 31, 2023 and December 31, 2024 are adjusted for certain items and should be considered a non-GAAP financial measure. A reconciliation of these non-GAAP financ
Slide 5: Revenue mix and reimbursement by payor
5 56.3% 12.9% 30.8% Home Health Revenue Medicare FFS Private Episodic Per Visit & Case Rate 63.0% 35.6% 1.4% Amedisys Consolidated Revenue Home Health Hospice High Acuity Care • Medicare FFS: Reimbursed for a 30-day period of care • Private Episodic: MA and Commercial plans who reimburse us for a 30
Slide 6: Home Health and Hospice Segment (Adjusted) – 4Q'24
6 HOME HEALTH AND HOSPICE SEGMENT (ADJUSTED) – 4Q’24(1) • Medicare revenue per episode up 1.1% primarily due to the rate increase effective 1/1/2024. • Y/Y Total CPV up $4.12 (+3.4%) primarily due to raises, wage inflation and higher health insurance costs. • EBITDA margin decreased 160 basis points
Slide 7: General & Administrative Expenses – Adjusted
7 GENERAL & ADMINISTRATIVE EXPENSES – ADJUSTED (1,2) Notes: • Year over year total G&A as a percentage of revenue decreased 60 basis points • $5.7 million increase in total G&A is primarily due to planned wage increases, higher incentive compensation costs and travel/training spend. • Total G&A incr
Slide 8: Operational Excellence: Home Health Cost Per Visit (CPV)-Adjusted
8 $25.00 $50.00 $75.00 $100.00 $125.00 4Q23 3Q24 4Q24 Cost Per Visit (CPV) Salaries Contractors Benefits Transportation OPERATIONAL EXCELLENCE: HOME HEALTH COST PER VISIT (CPV)-ADJUSTED YOY Total CPV impacted by higher labor costs and health insurance costs. *Note: Direct comparison with industry co
Slide 9: Driving Top Line Growth
9 DRIVING TOP LINE GROWTH 5% 8% 9% 9% 7% 7% 10% 13% 12% 8% 0.0% 4.0% 8.0% 12.0% 16.0% 120,000 130,000 140,000 150,000 160,000 4Q23 1Q24 2Q24 3Q24 4Q24 Volume SS Volume Growth SS Admit Growth Home Health Growth Hospice Growth -0.2% 0.3% 0.4% 0.5% 0.5% -2.0% -1.0% 0.0% 1.0% 12,700 12,800 12,900 13,000
Slide 10: Industry Leading Quality Scores
10 INDUSTRY LEADING QUALITY SCORES Quality of Patient Care (QPC) Patient Satisfaction (PS) • Amedisys maintains a 4-Star average in the Jan 2025 HHC Final release with 88% of our providers (representing 88% of care centers) at 4+ Stars and 46% of our providers (representing 42% of care centers) at 4
Slide 11: Hospice Quality: Amedisys Hospice Continues to Move Towards Best-in-Class
11 HOSPICE QUALITY: AMEDISYS HOSPICE CONTINUES TO MOVE TOWARDS BEST-IN-CLASS Hospice Quality Notes: Included in the above analysis are only active providers. CMS Nat is an average of all providers nationally, excluding active AMED providers. Exhibit 99.2
Slide 12: Debt and Liquidity Metrics
12 DEBT AND LIQUIDITY METRICS Net leverage ~0.3x 1. Net debt defined as total debt outstanding ($378.9M) less cash and cash equivalents ($303.2M). 2. Leverage ratio (net) is defined as net debt divided by last twelve months adjusted EBITDA ($245.8M). 3. Liquidity defined as the sum of cash balance a
Slide 13: Cash Flow Statement Highlights
13 CASH FLOW STATEMENT HIGHLIGHTS (1) Total cash flow from operations for 4Q’24 positively impacted by the timing of the payment of accounts payable and accrued expenses. 1. Free cash flow defined as cash flow from operations less routine capital expenditures and required debt repayments. $ in Milli
Slide 14: Income Statement Adjustments
14 INCOME STATEMENT ADJUSTMENTS (1) 1. The financial results for the three-month periods ended December 31, 2023, March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 are adjusted for certain items and should be considered a non-GAAP financial measure. A reconciliation of these no